| Address: | suite 3 level 4/828 Pacific Hwy, Gordon NSW 2072, Australia |
|---|---|
| Postal code: | 2072 |
| Phone: | (02) 9144 2223 |
| Website: | http://www.noxopharm.com/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Noxopharm Limited, use the form below and your opinion, advice or comment will appear in this space.
Noxopharm Limited Level 20, Tower A, The Zenith 821 Pacific Highway CHATSWOOD NSW 2067 or PO Box 292, Gordon 2072. NSW AUSTRALIA Telephone: + 61 2 9144 2223. ABN 50 608 966 123 . Contact us. Email Shareholder enquiries: info@noxopharm.com Patient enquiries: medical.information@noxopharm.com My shareholding:
Noxopharm Limited Tower A, The Zenith Level 20 821 Pacific Highway Chatswood, NSW 2067 Australia 61 2 9144 2223 https://www.noxopharm.com Sector(s) : Healthcare Industry : Biotechnology Full Time ...
Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company. The clinical stage drug candidate is Veyonda® (previously known as NOX-66). Veyonda® is a first-in-class, dual-acting cytotoxic and immuno-oncology drug candidate designed to enhance the effectiveness and safety of both chemotherapy and radiotherapy
+61 2 9144 2223. Turramurra, New South Wales Office. PO Box 828, Turramurra, New South Wales, 2074, Australia +61 2 9144 2223. Noxopharm Profile and History . Noxopharm Limited (ASX:NOX) is an Australian clinical-stage drug development company focused on the treatment of cancer and cytokine release syndrome (septic shock). ...
Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company. The clinical stage drug candidate is Veyonda® (previously known as NOX-66). Veyonda® is a first-in-class, dual-acting cytotoxic and immuno-oncology drug candidate designed to enhance the effectiveness and safety of both chemotherapy and radiotherapy
Noxopharm Limited (NOX) is a clinical-stage Australian drug development company with offices in Sydney and New York. ... 02 9144 2223 . info@noxopharm.com. www.noxopharm.com. Lists and Charts. Share Price. Closing price for the last 90 trading days. View Full Chart.
See all company news (17.May.2022) European Patent to Be Granted for Cholesterol-Lowering Drug (29.Mar.2022) FDA Grants Orphan Drug Designation to Noxopharm for Sarcoma Treatment (08.Mar.2022) Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles
View Olivier Laczka's business profile as Group Chief Scientific Officer at Noxopharm Limited. Find Olivier's email address, mobile number, work history, and more.
Noxopharm Limited (ASX:NOX) Share Price Today, Stock News and Charts, fundamentals and dividend information, Trends, Announcements and Unique Analysis on Kalkine Media.
View Mark Waring's business profile as Senior VP US Operations at Noxopharm Limited. Find Mark's email address, mobile number, work history, and more.